Adverse drug reactions: Dermatological experience

Giornale Italiano di Dermatologia e Venereologia

Volumn 141, Issue 1, 2006, Pages 17-20

  Ayala, F ^a   Fabbrocini, G ^a   Bartiromo, F ^a   Barberio, E ^a   Rescigno, O ^a   Di Simone, L ^a   Capasso, C ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Drug response; Pharmaceutical Preparations, adverse effects; Skin

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC ANALGESIC AGENT; ANTIRETROVIRUS AGENT; CORTICOSTEROID; DAPSONE; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SPASMOLYTIC AGENT; SULFONAMIDE;

ADOLESCENT; ADULT; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTHRALGIA; ARTICLE; CHILD; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG SAFETY; DYSPNEA; EPISTAXIS; ERYTHEMA NODOSUM; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; INFANT; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARESTHESIA; PATIENT CARE; PRURITUS; RASH; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; STOMATITIS; TOXIC EPIDERMAL NECROLYSIS; UNCONSCIOUSNESS; URTICARIA;

EID: 33645126649     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sushma M, Noel MV, Ritika MC, James J, Guido S. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf 2005;14:1-39.
2. Knowles S, Shapiro L, Shear N. Reactive metabolites and adverse drug reactions: clinical considerations. Rev Allergy Immunol 2003; 24:229-38.
3. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001;53:357-79.
4. Boyd IW. The role of the Australian Adverse Drug Reactions Advisory Committee (ADRAC) in monitoring drug safety. Toxicology 2002;181-182:99-102.
5. Rotunda A, Hirsch RJ, Scheinfeld N, Weimberg JM. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venereol 2003;83:1-9.
6. Gruchalla RS. Drug allergy. J Allergy Clin Immunol 2003;1: 548-59.
7. Meisel C, Gerloff T, Kirchheiner J, Mrozikiewicz PM, Niewinski P, Brockmoller J et al. Implications of pharmacogenetics for individualizing drug treatment and for study design. J Mol Med 2003;81: 154-67.
8. Gautier S, Bachelet H, Bordet R, Caron J. The cost of adverse drug reactions. Expert Opin Pharmacother 2003;4:319-26.
9. Asakura E, Mori K, Komori Y, Takano M, Hasegawa T, Kobayashi W et al. The trend of the drug eruptions in the last fifteen years. Yakugaku Zasshi 2001;121:145-51.
10. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839-46.